Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cefodizime sodium | 86329-79-5 | 99.9% | 628.63 | 50 MG
SDP

Catalog No. 5000347366
Encompass_Preferred

Cefodizime sodium is a third-generation cephalosporin antibiotic with a broad spectrum of antibacterial activity. It has no renal toxic effect, good tolerance, and immune regulation activity. It can be used for the research of severe infections of the respiratory and urinary tracts.

  • Broad spectrum of antibacterial activity.
  • No renal toxic effect.
  • Good tolerance.
  • Immune regulation activity.
  • Suitable for research of severe respiratory and urinary tract infections.
  • Bactericidal antibiotic with high affinity for penicillin-binding proteins lA/B, 2, and 3 of E. coli.
  • Continues to show pronounced bactericidal activity for at least 48 hours after a single injection in studies.
  • Achieves complete bacterial clearance from the lung within 48 hours in 50% of mice in experimental studies.

Catalog No. 50-003-47366 Supplier Medchemexpress LLC Supplier No. HY108402A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Cefodizime sodium is a third-generation cephalosporin antibiotic with a broad spectrum of antibacterial activity. It has no renal toxic effect, good tolerance, and immune regulation activity. It can be used for the research of severe infections of the respiratory and urinary tracts.

  • Broad spectrum of antibacterial activity.
  • No renal toxic effect.
  • Good tolerance.
  • Immune regulation activity.
  • Suitable for research of severe respiratory and urinary tract infections.
  • Bactericidal antibiotic with high affinity for penicillin-binding proteins lA/B, 2, and 3 of E. coli.
  • Continues to show pronounced bactericidal activity for at least 48 hours after a single injection in studies.
  • Achieves complete bacterial clearance from the lung within 48 hours in 50% of mice in experimental studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.